Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives
Jieping Hu1, Gongxian Wang1, Ting Sun1
1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Abstract:
Androgen receptor plays a pivotal role in prostate cancer progression, and androgen deprivation therapy to intercept androgen receptor signal pathway is an indispensable treatment for most advanced prostate cancer patients to delay cancer progression. However, the emerging of castration-resistant prostate cancer reminds us the alteration of androgen receptor, which includes androgen receptor mutation, the formation of androgen receptor variants, and androgen receptor distribution in cancer cells. In this review, we introduce the process of androgen receptor and also its variants' formation, translocation, and function alteration by protein modification or interaction with other pathways. We dissect the roles of androgen receptor in prostate cancer from molecular perspective to provide clues for battling prostate cancer, especially castration-resistant prostate cancer.
Insights
Androgen receptor signaling is key in prostate cancer. Understanding its alterations, like mutations and variants, is crucial for treating advanced and castration-resistant prostate cancer effectively.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Androgen receptor (AR) signaling is central to prostate cancer (PC) progression.
- Androgen deprivation therapy (ADT) is a standard treatment for advanced PC, targeting AR signaling.
- The development of castration-resistant prostate cancer (CRPC) highlights AR alterations.
Purpose of the Study:
- To review the molecular mechanisms of AR alterations in PC.
- To explore AR variant formation, translocation, and functional changes.
- To provide insights into combating advanced and CRPC.
Main Methods:
- Literature review of AR signaling in prostate cancer.
- Analysis of AR mutation, variant formation, and cellular distribution.
- Examination of protein modification and pathway interactions affecting AR.
Main Results:
- AR alterations, including mutations and variants, are key to CRPC development.
- AR translocation and altered function are mediated by protein modifications and pathway crosstalk.
- AR plays a multifaceted role in both hormone-sensitive and castration-resistant PC.
Conclusions:
- Understanding AR molecular alterations is vital for developing novel therapeutic strategies.
- Targeting AR pathway modifications and interactions may overcome CRPC resistance.
- Further research into AR's molecular landscape can lead to improved PC management.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Internal Receptors
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


